Study Findings - Steve Barron
The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall.
Results from a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy 1 Final.
Therapeutic Drug Monitoring (TDM) of Tyrosine Kinase Inhibitors (TKI) in MRCC
1 Coiffier B et al. J Clin Oncol 2012;30(6):631-6 . Proc ASH 2011;Abstract 591.
Ołów we krwi osób spożywających dziczyznę
Knowledge and attitudes towards pandemic influenza at the University of Alberta Rob Lake; Olive Yonge; Tom Marrie; Tracey Bailey; Rhonda Rosychuk; Ben.
Presenter Disclosure Information
